Deprince Race & Zollo Inc. Purchases New Position in The Clorox Company $CLX

Deprince Race & Zollo Inc. acquired a new position in The Clorox Company (NYSE:CLX) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 124,717 shares of the company’s stock, valued at approximately $12,924,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Vermillion & White Wealth Management Group LLC bought a new stake in Clorox in the third quarter worth approximately $25,000. Darwin Wealth Management LLC acquired a new stake in shares of Clorox in the 2nd quarter valued at $29,000. Caitlin John LLC boosted its holdings in Clorox by 1,807.1% in the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares in the last quarter. Ameriflex Group Inc. boosted its holdings in Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after purchasing an additional 273 shares in the last quarter. Finally, Vision Financial Markets LLC increased its position in Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after buying an additional 200 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have weighed in on CLX. Citigroup reduced their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Evercore reissued an “underperform” rating and set a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. JPMorgan Chase & Co. cut their price objective on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. TD Cowen upped their target price on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Finally, Barclays lowered their price target on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat.com, Clorox has an average rating of “Reduce” and an average target price of $103.40.

Clorox Stock Up 0.8%

CLX stock opened at $97.15 on Friday. The stock has a market capitalization of $11.75 billion, a price-to-earnings ratio of 15.77, a price-to-earnings-growth ratio of 0.45 and a beta of 0.54. The company has a 50-day moving average of $94.21 and a two-hundred day moving average of $104.28. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the company posted $1.45 earnings per share. The firm’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 5.61 EPS for the current year.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.